Skip to main content
Table of Contents
Print

Can Pregnant or Breastfeeding Women Use Medical Cannabis Safely for Spondylolisthesis Symptoms? 

Author: Dr. Clarissa Morton, PharmD

The question of cannabis use during pregnancy is an important one for women managing spondylolisthesis . While cannabis may help with pain, stiffness, and sleep, its safety during pregnancy and breastfeeding remains uncertain, with most doctors advising against it. 

Concerns arise from potential effects on foetal development and infant health. Healthcare providers emphasise maternal safety and caution that even small amounts of cannabis could pose breastfeeding risks. 

Medical Guidance on Pregnancy And Cannabis Use 

Healthcare professionals highlight several key considerations when discussing cannabis use during pregnancy for spondylolisthesis patients: 

Maternal Safety 

Doctors prioritise maternal safety, noting that cannabis can affect circulation, mood, and cognitive function. These effects may complicate pregnancy and add risks for both mother and baby. 

Breastfeeding Risks 

Cannabinoids can pass into breast milk, creating potential breastfeeding risks for newborns. Long-term effects are still being studied, but most medical bodies recommend avoiding cannabis during breastfeeding. 

Safer Alternatives 

Instead of relying on cannabis, clinicians may recommend physiotherapy, gentle exercise, or carefully monitored pain relief methods. These provide safer ways to manage symptoms while reducing concerns linked to cannabis use during pregnancy. 

While cannabis can be effective for chronic pain, the evidence strongly suggests avoiding it during pregnancy and breastfeeding. Protecting maternal safety remains the priority in spondylolisthesis care. 

Visit providers like LeafEase for personalised consultations on safe alternatives to cannabis use during pregnancy in spondylolisthesis treatment. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Spondylolisthesis.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories